Sign in

NCT05033002Completed

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

Efficacy Testing of a Culturally Relevant Stigma Intervention With Women Living With HIV in Tanzania

Source: ClinicalTrials.gov · Last updated 29 May 2025

Brief summary (registry, in English)

This study will test a stigma reduction intervention with women living with HIV in Tanzania.

Status (registry)
Completed
Study type
Interventional
Enrollment
167 (actual)
First submitted
31 Aug 2021
Start date
24 Oct 2022
Primary completion date
16 May 2024
Lead sponsor
Duke University
Diseases
HIV
NCT number
NCT05033002

What you commit to

  • Study type: Interventional
  • Participants enrolled: 167
  • From 24 Oct 2022 to the primary completion date, 16 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • (2) Transgender women living with HIV will not be eligible to participate in this study to reduce the potential for confounding sources of stigma recognizing that a transgender identity is highly stigmatized and culturally sensitive in Tanzania. Further, it would be exceedingly difficult to recruit a sufficient sample of transgender women living with HIV to conduct an appropriate analysis.
  • (3) Participants may be enrolled in other HIV-related studies except cognitive-behavioral intervention studies addressing stigma, self-efficacy, self-esteem, and/or disclosure

Other

  • (1) any acute psychological or physiological distress; if there is evidence of acute psychologic and/or physiologic, they will be excluded from this study and referred to an appropriate site for evaluation and treatment.

Who the study is looking for

  • The inclusion criteria for this study are:
  • (1) women who are living with HIV;
  • (2) age 18 (age of adulthood as defined by the Tanzanian government);
  • (3) able and willing to voluntarily consent to participate in the study;
  • (4) able to travel to a data collection in their local community (as described above);
  • (5) demonstrate mental competence at time of informed consent;
  • (6) verbally indicate that they plan to reside in their current community for at least 6 months after enrollment (necessary to prevent attrition);
  • (7) score at the median or higher level on the Swahili Version of the Multidimensional Measure of Internalized HIV Stigma Scale.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Muhimbili University of Health and Allied Sciences
Coordinator of this site? Confirm its status
Dar es SalaamTanzaniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.